Glass House Brands (GLAS) Change in Receivables (2020 - 2026)

Glass House Brands' (GLAS) quarterly Change in Receivables came in at -$2.1 million in Q1 2026, down 47.19% year-on-year from -$4.0 million in Q1 2025, and down 239.36% on a QoQ basis from $1.5 million in Q4 2025.

Glass House Brands (GLAS) Change in Receivables (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Change in Receivables data on file, last reported at -$2.1 million in Q1 2026.

  • On a quarterly basis, Change in Receivables fell 47.19% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was -$125000.0, a 86.47% increase from a year earlier, with the FY2025 full-year figure at $547000.0, down 63.07% from the prior year.
  • Change in Receivables for Q1 2026 stood at -$2.1 million, down from $1.5 million in the prior quarter.
  • Over the last five years, Change in Receivables for GLAS reached as high as $5.6 million in Q4 2024 and fell as low as -$4.9 million in Q2 2024.
  • Historically, Change in Receivables has averaged $21259.8 across 5 years, with a median of $277000.0 in 2022.
  • Across the five-year window, Change in Receivables slumped 2147.95% in 2022 and soared 3267.94% in 2024, its largest moves.
  • Year by year, Change in Receivables stood at $842000.0 in 2022, then tumbled by 80.2% to $166719.0 in 2023, then surged by 3267.94% to $5.6 million in 2024, then slumped by 73.21% to $1.5 million in 2025, then slumped by 239.36% to -$2.1 million in 2026.
  • Per Business Quant data, the three most recent Change in Receivables figures were -$2.1 million in Q1 2026, $1.5 million in Q4 2025, and $3.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -78.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -38.20 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn -2.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.10 Mn
Mar 31, 2026 -2.10 Mn
Dec 31, 2025 1.50 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 3.72 Mn
Sep 30, 2025 3.72 Mn
Jun 30, 2025 -3.25 Mn
Jun 30, 2025 -3.25 Mn
Mar 31, 2025 -1.42 Mn
Mar 31, 2025 -1.42 Mn
Dec 31, 2024 5.62 Mn
Dec 31, 2024 5.62 Mn
Sep 30, 2024 -251,000.00
Sep 30, 2024 -251,000.00
Jun 30, 2024 -4.86 Mn
Jun 30, 2024 -4.86 Mn
Mar 31, 2024 981,000.00
Mar 31, 2024 981,000.00
Dec 31, 2023 166,719.00
Dec 31, 2023 166,719.00